ALPS Advisors’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-67,599
| Closed | -$781K | – | 872 |
|
|
2019
Q3 | $781K | Sell |
67,599
-3,068
| -4% | -$35.4K | 0.01% | 351 |
|
|
2019
Q2 | $706K | Sell |
70,667
-13,178
| -16% | -$132K | 0.01% | 439 |
|
|
2019
Q1 | $1.08M | Buy |
83,845
+4,036
| +5% | +$52K | 0.01% | 310 |
|
|
2018
Q4 | $1.21M | Buy |
79,809
+18,806
| +31% | +$286K | 0.01% | 267 |
|
|
2018
Q3 | $1.22M | Buy |
61,003
+11,187
| +22% | +$224K | 0.01% | 331 |
|
|
2018
Q2 | $971K | Buy |
49,816
+4,096
| +9% | +$79.8K | 0.01% | 343 |
|
|
2018
Q1 | $921K | Sell |
45,720
-8,047
| -15% | -$162K | 0.01% | 329 |
|
|
2017
Q4 | $712K | Buy |
53,767
+19,015
| +55% | +$252K | ﹤0.01% | 324 |
|
|
2017
Q3 | $641K | Buy |
34,752
+3,119
| +10% | +$57.5K | ﹤0.01% | 327 |
|
|
2017
Q2 | $582K | Buy |
31,633
+2,091
| +7% | +$38.5K | ﹤0.01% | 375 |
|
|
2017
Q1 | $666K | Sell |
29,542
-3,334
| -10% | -$75.2K | ﹤0.01% | 262 |
|
|
2016
Q4 | $1.14M | Sell |
32,876
-10,664
| -24% | -$371K | 0.01% | 209 |
|
|
2016
Q3 | $1.07M | Sell |
43,540
-22,416
| -34% | -$549K | 0.01% | 221 |
|
|
2016
Q2 | $1.58M | Buy |
65,956
+8,218
| +14% | +$197K | 0.01% | 186 |
|
|
2016
Q1 | $1.35M | Buy |
57,738
+2,145
| +4% | +$50.2K | 0.01% | 174 |
|
|
2015
Q4 | $1.68M | Buy |
55,593
+45,716
| +463% | +$1.38M | 0.02% | 187 |
|
|
2015
Q3 | $3.92K | Buy |
+9,877
| New | +$3.92K | ﹤0.01% | 629 |
|